Bridge Creek Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bridge Creek Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$2.19M	Sell	4,511 -454	-9%	-$211K	0.61%	64
2025 Q2	$2.01M	Buy	4,965 +866	+21%	+$362K	0.59%	64
2025 Q1	$2.04M	Buy	4,099 +33	+0.8%	+$17.9K	0.64%	62
2024 Q4	$2.12M	Buy	4,066 +15	+0.4%	+$8.25K	0.65%	62
2024 Q3	$2.51M	Hold	4,051	–	–	0.76%	59
2024 Q2	$2.24M	Hold	4,051	–	–	0.72%	63
2024 Q1	$2.35M	Buy	4,051 +15	+0.4%	+$8.42K	0.75%	62
2023 Q4	$2.14M	Buy	4,036 +152	+4%	+$73.6K	0.74%	59
2023 Q3	$1.97M	Buy	3,884 +15	+0.4%	+$7.99K	0.75%	60
2023 Q2	$2.02M	Hold	3,869	–	–	0.72%	60
2023 Q1	$2.23M	Sell	3,869 -15	-0.4%	-$8.45K	0.84%	54
2022 Q4	$2.14M	Buy	3,884 +270	+7%	+$143K	0.84%	55
2022 Q3	$1.83M	Buy	3,614 +239	+7%	+$134K	0.79%	53
2022 Q2	$1.83M	Buy	3,375 +383	+13%	+$211K	0.75%	56
2022 Q1	$1.77M	Buy	2,992 +1,197	+67%	+$688K	0.59%	61
2021 Q4	$1.2M	Sell	1,795 -55	-3%	-$34.3K	0.4%	65
2021 Q3	$1.06M	Buy	1,850 +25	+1%	+$13.7K	0.39%	68
2021 Q2	$921K	Buy	1,825 +1,155	+172%	+$545K	0.34%	71
2021 Q1	$306K	Buy	670 +235	+54%	+$112K	0.12%	94
2020 Q4	$203K	Buy	+435	New	+$204K	0.08%	91

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bridge Creek Capital Management's TMO Position: Q3 2025 in Review

Bridge Creek Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 9.1% in Q3 2025, selling an estimated $211K and leaving 4,511 shares worth $2.19M. The position accounts for 0.61% of the portfolio, ranked #64.

Bridge Creek Capital Management first reported a position in TMO in Q4 2020 and has held it in 20 quarters since. The position peaked at $2.51M in Q3 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Bridge Creek Capital Management held 4,511 shares of Thermo Fisher Scientific worth $2.19M as of Q3 2025.
Bridge Creek Capital Management sold 454 Thermo Fisher Scientific shares in Q3 2025, an estimated $211K.
Thermo Fisher Scientific made up 0.61% of Bridge Creek Capital Management's portfolio in Q3 2025, its #64 holding.
Bridge Creek Capital Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 20 quarters since.
Bridge Creek Capital Management's Thermo Fisher Scientific position peaked at $2.51M in Q3 2024.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Bridge Creek Capital Management's 13F filing for Q3 2025, filed 14 Oct 2025.